Kewaunee Scientific (KEQU) Reports Steep Q4 Profit, Sales Decline

Kewaunee Scientific Corporation (NASDAQ: KEQU) announced a significant decline in its fourth-quarter profit and sales for the period ending April 30, 2026. Net income for the quarter fell to $1.1 million, or $0.40 per share, a substantial decrease from $2.4 million, or $0.85 per share, reported in the same quarter last year. The company's Q4 sales also decreased to $47.3 million, down from $54.2 million year-over-year. For the full fiscal year 2026, Kewaunee Scientific recorded net income of $6.7 million, or $2.37 per share, compared to $9.6 million, or $3.40 per share, in fiscal year 2025. Total sales for fiscal year 2026 reached $197.6 million, a decrease from $212.7 million in the prior fiscal year.